Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.

NCT00156806 is registered in ClinicalTrials.gov with AHS Cancer Control Alberta as lead sponsor.

NCT NCT00156806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00156806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.
Lead sponsor
AHS Cancer Control Alberta
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2002
Completion date
May 31, 2006
Enrollment
231
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer